Cargando…
Impact of systemic anticancer therapy in pediatric optic pathway glioma on visual function: A systematic review
Pediatric optic pathway glioma (OPG) can seriously decrease visual function in the case of progression. Systemic anticancer therapy (SAT) is considered the treatment of first choice for unresectable OPG. New SAT modalities for the treatment of progressive OPG have been introduced in the last decade,...
Autores principales: | Bennebroek, Carlien A. M., Wijninga, Laura. E., Limpens, Jaqueline, Schouten-van Meeteren, Antoinette Y. N., Saeed, Peerooz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8530362/ https://www.ncbi.nlm.nih.gov/pubmed/34673789 http://dx.doi.org/10.1371/journal.pone.0258548 |
Ejemplares similares
-
Impact of Bevacizumab on Visual Function, Tumor Size, and Toxicity in Pediatric Progressive Optic Pathway Glioma: A Retrospective Nationwide Multicentre Study
por: Bennebroek, Carlien A. M., et al.
Publicado: (2022) -
Tocilizumab for the fifth progression of cystic childhood craniopharyngioma—a case report
por: de Vos-Kerkhof, Evelien, et al.
Publicado: (2023) -
Current and emerging treatment strategies for children with progressive chiasmatic-hypothalamic glioma diagnosed as infants: a web-based survey
por: Azizi, Amedeo A., et al.
Publicado: (2017) -
Pediatric Optic Pathway/Hypothalamic Glioma
por: AIHARA, Yasuo, et al.
Publicado: (2018) -
Pediatric Glioma at the Optic Pathway and Thalamus
por: Park, Eun Suk, et al.
Publicado: (2018)